The research behind the platform

These papers map the science of analyzing volatile compounds in the headspace above urine and other biofluids: how those measurements are taken, what the resulting chemical signatures contain, and how they relate to human physiology and to the detection of disease. They describe the research field as a whole, not any single CareTech Human product. Below, they are grouped as six questions — from what the body emits to how a personal baseline is built.

  1. 01

    Is there anything to measure?

    The human volatilome

    What the body emits, and how it is measured.

  2. 02

    Can an instrument read it?

    Digital olfaction

    How a machine reads a smell.

  3. 03

    Does ordinary life change it?

    Everyday physiology

    Exertion, digestion and recovery are visible in volatile chemistry.

  4. 04

    Has anything serious been caught this way?

    What volatile compounds have detected

    Peer-reviewed clinical work on detecting disease from volatile signatures — part of the research field, not a product claim.

    ACS Nano · 2017

    Diagnosis and classification of 17 diseases from 1404 subjects via pattern analysis of exhaled molecules

    Nakhleh et al.

    The largest clinical test of a sensor array to date. Breath from 1,404 subjects with one of 17 conditions or none; blind experiments reached 86% accuracy, each condition showed its own pattern, and the result was cross-checked against GC-MS.

    Biosensors · 2020

    Sniffing out urinary tract infection: diagnosis based on volatile organic compounds and smell profile

    Dospinescu, Tiele & Covington

    Reviews how mass spectrometry, ion mobility spectrometry and electronic noses read volatiles from urine headspace to identify a bacterial pathogen, in some work within minutes rather than the 24 to 72 hours a culture takes.

    Biosensors · 2018

    Non-invasive diagnosis of diabetes by volatile organic compounds in urine using FAIMS and Fox4000 electronic nose

    Esfahani et al.

    140 urine samples, 73 from people with type 2 diabetes and 67 from healthy controls, analyzed with two different electronic nose technologies. A metabolic state, not an infection, separated on urinary volatiles alone.

    Metabolites · 2020

    Urinary volatile organic compound analysis for the diagnosis of cancer: a systematic literature review and quality assessment

    Wen et al.

    Thirteen studies and 1,266 participants across five cancer types. Forty-eight urinary compounds showed high diagnostic performance and the profiles were distinctive per cancer type, though the authors note that differences in study design produced inconsistencies between studies.

  5. 05

    Why the bathroom?

    The toilet as a measurement point

    Why the bathroom, and what it takes to do this at home.

  6. 06

    Why does it take time?

    Why a personal baseline

    One reading is a snapshot. The comparison that matters is you against yourself.

Building on this field with us?

We talk with clinicians, researchers and partners who want to put passive volatile sensing to work.